{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:49:03Z","timestamp":1790984943891,"version":"4.1.0"},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T00:00:00Z","timestamp":1451347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T00:00:00Z","timestamp":1451347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Surg. Oncol."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1002\/jso.24140","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T09:46:57Z","timestamp":1451382417000},"page":"438-442","source":"Crossref","is-referenced-by-count":14,"title":["Both heat and new chemotherapeutic drug dioxadet in hyperthermic intraperitoneal chemoperfusion improved survival in rat ovarian cancer model"],"prefix":"10.1002","volume":"113","author":[{"given":"Vladimir G.","family":"Bespalov","sequence":"first","affiliation":[{"name":"Department of Cancer Chemoprevention and Oncopharmacology in N.N. Petrov Research Institute of Oncology of the Russian Ministry of Health; 68, Leningradskaya Street, Pesochny; Saint-Petersburg Russia"},{"name":"ITMO University; 49, Kronverksky Avenue; Saint-Petersburg Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina S.","family":"Kireeva","sequence":"additional","affiliation":[{"name":"Department of Cancer Chemoprevention and Oncopharmacology in N.N. Petrov Research Institute of Oncology of the Russian Ministry of Health; 68, Leningradskaya Street, Pesochny; Saint-Petersburg Russia"},{"name":"ITMO University; 49, Kronverksky Avenue; Saint-Petersburg Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olesya A.","family":"Belyaeva","sequence":"additional","affiliation":[{"name":"Department of Cancer Chemoprevention and Oncopharmacology in N.N. Petrov Research Institute of Oncology of the Russian Ministry of Health; 68, Leningradskaya Street, Pesochny; Saint-Petersburg Russia"},{"name":"ITMO University; 49, Kronverksky Avenue; Saint-Petersburg Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksiy E.","family":"Kalinin","sequence":"additional","affiliation":[{"name":"Lugansk Oncological Dispensary, Lugansk, Ukraine; 8, Krasnodonskaya Street; Lugansk Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin Y.","family":"Senchik","sequence":"additional","affiliation":[{"name":"Department of Cancer Chemoprevention and Oncopharmacology in N.N. Petrov Research Institute of Oncology of the Russian Ministry of Health; 68, Leningradskaya Street, Pesochny; Saint-Petersburg Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr N.","family":"Stukov","sequence":"additional","affiliation":[{"name":"Department of Cancer Chemoprevention and Oncopharmacology in N.N. Petrov Research Institute of Oncology of the Russian Ministry of Health; 68, Leningradskaya Street, Pesochny; Saint-Petersburg Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgy I.","family":"Gafton","sequence":"additional","affiliation":[{"name":"Department of Cancer Chemoprevention and Oncopharmacology in N.N. Petrov Research Institute of Oncology of the Russian Ministry of Health; 68, Leningradskaya Street, Pesochny; Saint-Petersburg Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin D.","family":"Guseynov","sequence":"additional","affiliation":[{"name":"Department of Cancer Chemoprevention and Oncopharmacology in N.N. Petrov Research Institute of Oncology of the Russian Ministry of Health; 68, Leningradskaya Street, Pesochny; Saint-Petersburg Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey M.","family":"Belyaev","sequence":"additional","affiliation":[{"name":"Department of Cancer Chemoprevention and Oncopharmacology in N.N. Petrov Research Institute of Oncology of the Russian Ministry of Health; 68, Leningradskaya Street, Pesochny; Saint-Petersburg Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,12,29]]},"reference":[{"key":"10.1002\/jso.24140-BIB0001|jso24140-cit-0001","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1002\/jso.24140-BIB0002|jso24140-cit-0002","first-page":"803","article-title":"Randomized phase III study of intravenous (IV) paclitaxel and cisplatin versus IV paclitaxel, intraperitoneal (IP) cisplatin and IP paclitaxel in optimal stage III epithelial ovarian cancer (OC): A gynecologic oncology group trial (GOG 172)","volume":"21","author":"Armstrong","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1002\/jso.24140-BIB0003|jso24140-cit-0003","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ygyno.2008.10.028","article-title":"Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest oncology group study S0009","volume":"112","author":"Tiersten","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1002\/jso.24140-BIB0004|jso24140-cit-0004","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/cncr.22467","article-title":"Results of the 2006 innsbruck international consensus conference on intraperitoneal chemotherapy in patients with ovarian cancer","volume":"109","author":"Marth","year":"2007","journal-title":"Cancer"},{"key":"10.1002\/jso.24140-BIB0005|jso24140-cit-0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2005.11.013","article-title":"Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitonealchemotherapy in optimal stage III ovarian and primary peritoneal cancer: A gynecologic oncology group study","volume":"100","author":"Walker","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1002\/jso.24140-BIB0006|jso24140-cit-0006","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.2174\/138161212802002616","article-title":"Survival benefit of adding hyperthermic intraperitoneal chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: Review of evidence","volume":"18","author":"Mulier","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1002\/jso.24140-BIB0007|jso24140-cit-0007","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1245\/s10434-013-3407-6","article-title":"Melphalan: A promising agent in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"21","author":"Sardi","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1002\/jso.24140-BIB0008|jso24140-cit-0008","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00280-006-0229-2","article-title":"Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor","volume":"58","author":"Mohamed","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1002\/jso.24140-BIB0009|jso24140-cit-0009","first-page":"216","article-title":"Multicenter clinical trial of the antitumor drug Dioxadet (phase II)","volume":"44","author":"Gershanovich","year":"1998","journal-title":"Vopr Onkol"},{"key":"10.1002\/jso.24140-BIB0010|jso24140-cit-0010","first-page":"770","article-title":"Antitumor action of dioxadet in comparison with cisplatin in a rat model of ascetic ovarian cancer","volume":"57","author":"Bespalov","year":"2011","journal-title":"Vopr Onkol"},{"key":"10.1002\/jso.24140-BIB0011|jso24140-cit-0011","first-page":"714","article-title":"Use of dioxadet for chemoembolization of hepatic artery in primary and metastatic liver cancer","volume":"44","author":"Borisov","year":"1998","journal-title":"Vopr Onkol"},{"key":"10.1002\/jso.24140-BIB0012|jso24140-cit-0012","first-page":"711","article-title":"Results of endovascular interventions (embolization and chemoembolization) in the treatment of operable and advanced kidney cancer","volume":"44","author":"Granov","year":"1998","journal-title":"Vopr Onkol"},{"key":"10.1002\/jso.24140-BIB0013|jso24140-cit-0013","first-page":"29","article-title":"Transplantable ascitic ovary tumour of the rat","volume":"8","author":"Pogosiants","year":"1962","journal-title":"Vopr Onkol"},{"key":"10.1002\/jso.24140-BIB0014|jso24140-cit-0014","first-page":"71","article-title":"Experimental technology of chemoperfusion treatment for abdominal carcinomatosis in ovarian cancer","volume":"60","author":"Belyaeva","year":"2014","journal-title":"Vopr Onkol"},{"key":"10.1002\/jso.24140-BIB0015|jso24140-cit-0015","unstructured":"2000 https:\/\/clinicaltrials.gov\/ct2\/show\/record\/N CT02124421"},{"key":"10.1002\/jso.24140-BIB0016|jso24140-cit-0016","unstructured":"2000 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01628380"},{"key":"10.1002\/jso.24140-BIB0017|jso24140-cit-0017","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3747\/co.v18i2.725","article-title":"Phase II\/III study of intraperitoneal chemotherapy after neoadjuvant chemotherapy for ovarian cancer","volume":"18","author":"Mackay","year":"2011","journal-title":"Curr Oncol"},{"key":"10.1002\/jso.24140-BIB0018|jso24140-cit-0018","unstructured":"2006 ctep.cancer.gov\/highlights\/docs\/clin_annc_010506.pdf"},{"key":"10.1002\/jso.24140-BIB0019|jso24140-cit-0019","first-page":"25","article-title":"Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer","volume":"25","author":"Jaaback","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1002\/jso.24140-BIB0020|jso24140-cit-0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/GCO.0b013e32831f8f32","article-title":"Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer","volume":"21","author":"Sugarbaker","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1002\/jso.24140-BIB0021|jso24140-cit-0021","first-page":"2803","article-title":"Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancer","volume":"29","author":"Zeimet","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1002\/jso.24140-BIB0022|jso24140-cit-0022","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00432-009-0667-4","article-title":"Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: Systematic review of current results","volume":"135","author":"Chua","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1002\/jso.24140-BIB0023|jso24140-cit-0023","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2011.05.004","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: A multi-institutional Phase-II trial","volume":"122","author":"Deraco","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1002\/jso.24140-BIB0024|jso24140-cit-0024","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/IGC.0b013e3181c50cde","article-title":"HIPEC in ovarian cancer: First report of HYPER-O registry","volume":"20","author":"Helm","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1002\/jso.24140-BIB0025|jso24140-cit-0025","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ejso.2009.03.004","article-title":"Cytoreductive surgery and modified heated intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer-12-year single center experience","volume":"35","author":"Pavlov","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1002\/jso.24140-BIB0026|jso24140-cit-0026","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1525-1438.2001.11(suppl.1)sup1057.x","article-title":"Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer","volume":"11","author":"Hager","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"10.1002\/jso.24140-BIB0027|jso24140-cit-0027","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2004.05.044","article-title":"Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer","volume":"94","author":"Ryu","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1002\/jso.24140-BIB0028|jso24140-cit-0028","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jso.21448","article-title":"Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer","volume":"101","author":"Kim","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1002\/jso.24140-BIB0029|jso24140-cit-0029","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jso.20597","article-title":"Radical surgery peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer","volume":"94","author":"Rufi\u00e1n","year":"2006","journal-title":"J Surg Oncol"},{"key":"10.1002\/jso.24140-BIB0030|jso24140-cit-0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4161\/cbt.213","article-title":"Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: Better than commonly perceived-but they can be improved","volume":"2","author":"Kerbel","year":"2003","journal-title":"Cancer Biol Ther"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.24140","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.24140","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jso.24140\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T09:58:01Z","timestamp":1625306281000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.24140"}},"subtitle":["Both Heat and New Chemotherapeutic Drug"],"short-title":[],"issued":{"date-parts":[[2015,12,29]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,3]]}},"URL":"https:\/\/doi.org\/10.1002\/jso.24140","archive":["Portico"],"relation":{},"ISSN":["0022-4790"],"issn-type":[{"value":"0022-4790","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12,29]]}}}